08192018Headline:

Chromatography Resin Market Industry Leaders & New Revenue Pockets

The chromatography resin market is projected to grow from USD 1.72 billion in 2016 to USD 2.46 billion by 2021, at a CAGR of 7.41% from 2016 to 2021. The demand for chromatography resins is increasing due to their increasing usage in therapeutic applications.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=933

Some of the major players operating in this market include GE Healthcare (U.S.), Merck KGaA (Germany), Pall Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Tosoh Corporation (Japan), Purolite Corporation (U.S.), Repligen Corporation (U.S.), Mitsubishi Chemical Corporation (Japan), and Avantor Performance Materials Inc. (U.S.). These players have adopted various strategies to expand their global presence and increase their market shares.

The growth of the chromatography resin market was largely influenced by new product launches and expansions during the past five years. New product launches and expansions, contracts & agreements, and acquisitions are some of the strategies adopted by these players to achieve growth in the market. Companies such as GE Healthcare (U.S.), Merck KGaA (Germany), Pall Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Tosoh Corporation (Japan) adopted strategies such as new product launches and expansions to strengthen their market position and widen their product portfolio.

GE Healthcare, the leading chromatography resin company, adopted various strategies such as contracts & new product launches, and investments to widen its product portfolio. For instance, in June 2016, GE Healthcare launched Capto Q XP, a strong anion exchange chromatography resin. The company also invested USD 100 million in 2015 in a manufacturing facility in Uppsala, Sweden. This strategy will enable the company to increase its chromatography resin manufacturing capacity.

Tosoh Corporation has undertaken several new product launches to provide chromatography resins for different chromatography techniques to its customers. For instance, Tosoh Corporation launched TOYOPEARL Sulfate-650F in 2016, a strong cation exchange resin that exhibits high salt tolerance. This resin is available for sale in the Americas from Tosoh Bioscience LLC. Tosoh Corporation is focused on expanding and improving its chromatography business segment through the development of innovative products and technologies. The company has a significant presence in Asia-Pacific and is now focused on increasing its market share in Europe and North America.

The pharmaceutical & biotechnology segment is projected to play a key role in the chromatography resin market and grow at a considerable growth rate from 2016 to 2021.

The chromatography resin market is projected to grow from USD 1.72 billion in 2016 to USD 2.46 billion by 2021, at a CAGR of 7.41% from 2016 to 2021. On the basis of type, this market is segmented into natural polymer, synthetic polymer, and inorganic media. The demand for synthetic polymer is expected to be driven by their use in ion exchange chromatography. Polystyrene divinylbenzene is the most commonly used synthetic polymer, which is being increasingly used in ion exchange applications because of its better performance in comparison to the natural polymer.

Based on application, the pharmaceutical & biotechnology segment of the chromatography resin market is projected to grow at a higher rate during the forecast period. Industrial-scale purification of biopharmaceuticals and quantitative and qualitative analysis of drugs are the key application areas of chromatography resin. Chromatography is increasingly used to manufacture biological drugs, such as monoclonal antibodies and other recombinant proteins, which have tremendous potential to treat diseases such as well as Alzheimer’s, cancer, and diabetes.

 The chromatography resin market in Asia-Pacific is projected to grow at the highest CAGR during the forecast period. The growth is attributed to the increasing growth of generic drugs and biosimilars in countries, such as China, India, and South Korea. A large number of global pharmaceutical players are setting up R&D centers in these countries because of economic benefits and availability of skilled professionals.

The chromatography resin market in North America accounted for the largest share in 2015, owing to rising demand for monoclonal antibody therapeutics in the region. The chromatography resin market in the region is expected to grow at a significant rate due to heavy market opportunities in the U.S., Canada, and Latin American countries.

Europe was the second-largest market for chromatography resin, in terms of volume, in 2015. Germany is the key market for chromatography resin in Europe. Austria and Switzerland are also significant markets for chromatography resins. The presence of some pharmaceutical manufacturers and research organizations in these countries positively influence the growth of the chromatography resin market in the region.

What Next?

Recent Articles